86 related articles for article (PubMed ID: 23776069)
21. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
22. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.
Duque J; Díaz-Muñoz MD; Fresno M; Iñiguez MA
Cell Signal; 2006 Aug; 18(8):1262-9. PubMed ID: 16326073
[TBL] [Abstract][Full Text] [Related]
24. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
25. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
[TBL] [Abstract][Full Text] [Related]
26. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
27. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
[TBL] [Abstract][Full Text] [Related]
28. Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expression by apigenin in mouse keratinocytes: role of USF transcription factors.
Van Dross RT; Hong X; Essengue S; Fischer SM; Pelling JC
Mol Carcinog; 2007 Apr; 46(4):303-14. PubMed ID: 17186551
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
31. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
Ding Z; Pan JQ
Ann Hematol; 2005 Mar; 84(3):183-7. PubMed ID: 15309528
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
33. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 polymorphisms and susceptibility to colorectal cancer: a meta-analysis.
Wang J; Guo X; Zhang J; Song J; Ji M; Yu S; Wang J; Cao Z; Dong W
Yonsei Med J; 2013 Nov; 54(6):1353-61. PubMed ID: 24142638
[TBL] [Abstract][Full Text] [Related]
35. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
36. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains.
Zhu Y; Hua P; Lance P
Cancer Res; 2003 Jan; 63(2):522-6. PubMed ID: 12543811
[TBL] [Abstract][Full Text] [Related]
39. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]